34 results
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
8-K/A
EX-3.3
MYMD
MyMD Pharmaceuticals Inc
26 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-3.2
MYMD
MyMD Pharmaceuticals Inc
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
13 Feb 24
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
4:57pm
8-K
EX-3.1
wfm3t8 mk6iteaz
21 Feb 23
MyMD Announces $15 Million Offering with Existing Investors
9:00am
8-K
EX-3.3
z30e8otcbxlv qfow2
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.2
en0j6e4f7d
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.1
xrafxfl6jyhwr
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.1
go0lcc
9 Sep 20
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-3.1
x0ixv721
27 Jul 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
qpnfwtqtnlgv
24 Mar 20
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
9:21am
8-K
EX-3.1
nxtahf
6 Jan 20
Departure of Directors or Certain Officers
5:24pm